Apellis Pharmaceuticals Inc (APLS) — Net Asset Quality Index
Apellis Pharmaceuticals Inc (APLS) has a Net Asset Quality Index of 38.3% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $1.08 Billion minus total liabilities of $667.61 Million yields net assets of $414.92 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Apellis Pharmaceuticals Inc defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Apellis Pharmaceuticals Inc Net Asset Quality Index Over Time (2013–2025)
This chart shows how Apellis Pharmaceuticals Inc's Net Asset Quality Index has evolved across 13 annual periods from 2013 to 2025. As of March 2026, the index stands at 38.3%, representing net assets of $414.92 Million against total assets of $1.08 Billion USD. Explore APLS operating cash flow to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Apellis Pharmaceuticals Inc (2013–2025)
The table below presents the year-by-year Net Asset Quality Index for Apellis Pharmaceuticals Inc from 2013 to 2025, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see market cap of Apellis Pharmaceuticals Inc.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 34.4% | $370.15 Million | $1.08 Billion | $705.11 Million | ▲ +8.6 pp |
| 2024 | 25.8% | $228.54 Million | $885.05 Million | $656.51 Million | ▲ +1.2 pp |
| 2023 | 24.7% | $194.52 Million | $788.73 Million | $594.21 Million | ▲ +2.3 pp |
| 2022 | 22.3% | $169.87 Million | $760.22 Million | $590.35 Million | ▼ -0.2 pp |
| 2021 | 22.5% | $198.66 Million | $881.76 Million | $683.10 Million | ▲ +1.2 pp |
| 2020 | 21.3% | $204.56 Million | $960.57 Million | $756.01 Million | ▲ +12.5 pp |
| 2019 | 8.8% | $34.23 Million | $389.24 Million | $355.02 Million | ▼ -70.3 pp |
| 2018 | 79.1% | $160.97 Million | $203.53 Million | $42.56 Million | ▼ -2.7 pp |
| 2017 | 81.8% | $148.94 Million | $182.13 Million | $33.19 Million | ▼ -5.0 pp |
| 2016 | 86.7% | $23.79 Million | $27.43 Million | $3.64 Million | ▼ -4.9 pp |
| 2015 | 91.6% | $34.98 Million | $38.18 Million | $3.20 Million | ▼ -0.8 pp |
| 2014 | 92.4% | $13.22 Million | $14.31 Million | $1.08 Million | ▲ +5.5 pp |
| 2013 | 87.0% | $4.52 Million | $5.20 Million | $676.96K | — |